These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9563802)

  • 21. Telomerase activity in the occurrence and progression of oral squamous cell carcinoma.
    Miyazaki Y; Yoshida N; Nozaki T; Inoue H; Kikuchi K; Kusama K
    J Oral Sci; 2015; 57(4):295-303. PubMed ID: 26666852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of telomerase activity, clinical prognosis and therapy in oral carcinogenesis.
    Ries JC; Hassfurther E; Steininger H; Kloss FR; Wiltfang J; Girod SC; Neukam FW
    Anticancer Res; 2001; 21(2A):1057-63. PubMed ID: 11396140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative assay of telomerase activity in head and neck squamous cell carcinoma and other tissues.
    Zhang S; Dong M; Teng X; Chen T
    Arch Otolaryngol Head Neck Surg; 2001 May; 127(5):581-5. PubMed ID: 11346437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of telomerase activity in dog tumors.
    Yazawa M; Okuda M; Setoguchi A; Nishimura R; Sasaki N; Hasegawa A; Watari T; Tsujimoto H
    J Vet Med Sci; 1999 Oct; 61(10):1125-9. PubMed ID: 10563290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
    Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
    Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Telomerase activity in oral squamous cell carcinoma and leukoplakia].
    Shimamoto H
    Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):125-33. PubMed ID: 11321801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of telomerase activity in saliva from oral squamous cell carcinoma patients.
    Zhong LP; Chen GF; Xu ZF; Zhang X; Ping FY; Zhao SF
    Int J Oral Maxillofac Surg; 2005 Jul; 34(5):566-70. PubMed ID: 16053879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research on expression of human papillomavirus type 16 and telomerase in oral lesions].
    Patiman ; Zhang Z; Cao J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Mar; 36(2):119-21. PubMed ID: 11812320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
    Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism.
    Opitz OG; Suliman Y; Hahn WC; Harada H; Blum HE; Rustgi AK
    J Clin Invest; 2001 Sep; 108(5):725-32. PubMed ID: 11544278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quantitative histochemical study of glucose-6-phosphate dehydrogenase activity in premalignant and malignant lesions of human oral mucosa.
    Evans AW; Johnson NW; Butcher RG
    Histochem J; 1983 May; 15(5):483-9. PubMed ID: 6874405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma.
    Hsieh PC; Chen YK; Tsai KB; Shieh TY; Chang YY; Chang JG; Wu HL; Lin SF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):257-67. PubMed ID: 19926498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions.
    Dorji T; Monti V; Fellegara G; Gabba S; Grazioli V; Repetti E; Marcialis C; Peluso S; Di Ruzza D; Neri F; Foschini MP
    Hum Pathol; 2015 Sep; 46(9):1275-81. PubMed ID: 26170010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
    Mao L; El-Naggar AK; Fan YH; Lee JS; Lippman SM; Kayser S; Lotan R; Hong WK
    Cancer Res; 1996 Dec; 56(24):5600-4. PubMed ID: 8971162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic and prognostic relevance of expression of human telomerase subunits in oral cancer.
    Lee BK; Diebel E; Neukam FW; Wiltfang J; Ries J
    Int J Oncol; 2001 Nov; 19(5):1063-8. PubMed ID: 11605010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase detection in body fluids.
    Hess JL; Highsmith WE
    Clin Chem; 2002 Jan; 48(1):18-24. PubMed ID: 11751534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions.
    Kyo S; Takakura M; Tanaka M; Kanaya T; Inoue M
    Int J Cancer; 1998 Feb; 79(1):66-70. PubMed ID: 9495361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
    Simícková M; Nekulová M; Pecen L; Cernoch M; Vagundová M; Pacovský Z
    Neoplasma; 2001; 48(4):267-73. PubMed ID: 11712677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.